Lubrisine Eye Drops Recalled for Infection Risk

Eye

The FDA announced a recall for Lubrisine Eye Drops on December 31, warning that non-sterile manufacturing processes could result in a severe eye infection or vision loss.

Furthermore, the recalled eye drops contain colloidal silver, which can cause permanent discoloration of the conjunctiva of the eye if the product is used for an extended period of time.

The recall involves Lubrisine Eye Drops in single 1-ounce dropper bottles with UPC Code #9238230723, including all lots manufactured after May 12, 2012 onward. The manufacturing date is located on the botto of the bottle.

They were distributed worldwide and nationwide in the U.S. through doctors, internet sales, wholesale and retail stores.

For more information, customers with questions are instructed to send an email to customercare@lubrisine.com or call 203-290-2992.

Source: Results RNA LLC Issues Voluntary Worldwide/Nationwide Recall of Lubrisine Eye Drops Due to Manufacturing Sterility Concerns and Undeclared Colloidal Silver